Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-05 | New | $15,084,670 | $15,084,670 | Equity Only | 06b | SEC link |
| 2021-08-19 | New | $6,298,504 | $6,298,504 | Equity Only | 06b | SEC link |
| 2020-08-14 | New | $2,865,125 | $2,865,125 | Debt Only | 06b | SEC link |
| 2018-06-01 | New | $8,253,117 | $8,253,117 | Equity Only | 06b | SEC link |
| 2014-11-12 | New | $410,000 | $410,000 | Equity Only | 06b | SEC link |
| 2014-07-11 | New | $1,592,697 | $1,592,697 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Deyaa Adib | Director |
| Mark Burns | Director, Executive |
| Don Dyer | Director |
| Thomas Graham | Director, Executive |
| Stacy Hock | Director |
| David Meeks | Director |
| Jeff Miller | Director |
| Jeffrey Miller | Director |
| Donald Mowat | Director |
| Rhonda Rhyne | Director |
| Larry Richards | Executive |
| John Rosling | Director |
| James Skaggs | Director |
| Roger Ulrich | Director |